Best Practices in the Development and Validation of Physiologically Based Biopharmaceutics Modeling. A Workshop Summary Report
Authors:
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 110 (2) , 584-593
Abstract
No abstract availableKeywords
Funding Information
- Center of Excellence in Regulatory Science and Innovation
- US Food & Drug Administration (U01FD005946)
This publication has 32 references indexed in Scilit:
- Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant PopulationsPLOS ONE, 2015
- Investigation of pH and Temperature Profiles in the GI Tract of Fasted Human Subjects Using the Intellicap® SystemJournal of Pharmaceutical Sciences, 2015
- Applications of In Vitro–In Vivo Correlations in Generic Drug Development: Case StudiesThe AAPS Journal, 2015
- Simulation of In Vitro Dissolution Behavior Using DDDPlus™AAPS PharmSciTech, 2014
- Application of Absorption Modeling to Predict Bioequivalence Outcome of Two Batches of Etoricoxib TabletsAAPS PharmSciTech, 2014
- Deciding on Success Criteria for Predictability of Pharmacokinetic Parameters from In Vitro Studies: An Analysis Based on In Vivo ObservationsDrug Metabolism and Disposition, 2014
- Microdosing and drug development: past, present and futureExpert Opinion on Drug Metabolism & Toxicology, 2013
- Understanding the Effect of API Properties on Bioavailability Through Absorption ModelingThe AAPS Journal, 2008
- Oral Absorption of Poorly Water-Soluble Drugs: Computer Simulation of Fraction Absorbed in Humans from a Miniscale Dissolution TestPharmaceutical Research, 2006
- The effects of pharmaceutical excipients on small intestinal transit.British Journal of Clinical Pharmacology, 1995